Product Information
BUSPIRONE HCL 30 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1149 per EA under NDC 00093520005. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093520005
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075022On Market Since
3/26/2004
Price Statistics
The NADAC for BUSPIRONE HCL 30 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 81.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1149 per EA |
|---|---|
| All-time high | $0.6324 (Jan 15, 2014) |
| All-time low | $0.0971 (May 22, 2024) |
| 52-week high | $0.1235 |
| 52-week low | $0.1098 |
| Median price | $0.2673 |
| Average price | $0.3102 |
| Largest weekly change | +36.0% (Jun 19, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 30 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1149 per EA (NDC 00093520005), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 30 MG TABLET has declined 81.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 30 MG TABLET?
Since Nov 28, 2013, the NADAC for BUSPIRONE HCL 30 MG TABLET has ranged from a low of $0.0971 (May 22, 2024) to a high of $0.6324 (Jan 15, 2014), with a median of $0.2673 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 30 MG TABLET?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUSPIRONE HCL 30 MG TABLET, is $0.1117 per EA — about 3% below BUSPIRONE HCL 30 MG TABLET.
Who manufactures BUSPIRONE HCL 30 MG TABLET?
BUSPIRONE HCL 30 MG TABLET (NDC 00093520005) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification